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The purpose of this study was to investigate the relationship of several variables to the healing of lesions 
in patients with American cutaneous leishmaniasis (ACL). The patients with clinical and/or laboratorial 
diagnoses of the disease were followed up for varying periods after treatment by clinical evaluation and 
indirect immunofluorescence assay (IFA), from September 2000 to December 2003. The lesions of 85.3% 
of the 163 patients had healed by their last return for clinical evaluation, and of these, 82.7% had negative 
IFA results, indicating an association between the healing of lesions and IFA negativity (p=0.000). In 
patients evaluated up to 120 days after treatment, there was a significant association between negative 
IFA results and the healing of lesions (p=0.0000). Logistic regression analysis showed that negative IFA 
results on patients’ first return after treatment predicted a 2.175 fold greater chance of lesion healing 
(p=0.0001). These results indicate an association between IFA negativity at the first return up to a period 
of 120 days, and the healing of lesions, and that the chances of healing are significantly higher in patients 
with negative IFA results at their first return after treatment.
Uniterms: Cutaneous leishmaniasis/treatment. Leishmania (Viannia) braziliensis. Cutaneous lesion/
healing.
O objetivo deste estudo foi investigar a associação de algumas variáveis para a cicatrização de 
lesões em pacientes com leishmaniose tegumentar americana (LTA). Os pacientes com diagnóstico 
clínico e laboratorial foram acompanhados depois do tratamento por avaliação clínica e reação de 
imunofluorescência indireta (IFI), de setembro de 2000 a dezembro de 2003. Dos 163 pacientes 85,3% 
apresentaram cicatrização das lesões no último retorno para a avaliação clínica e 82,7% destes tiveram a 
IFI negativa indicando uma associação entre a cicatrização das lesões e a negativação da IFI (p=0,000). 
Nos pacientes acompanhados até 120 dias depois do tratamento houve associação significativa entre 
os resultados negativos da IFI e a cicatrização das lesões (p=0,0000). A análise pela regressão logística 
mostrou que quando a IFI do primeiro retorno após o tratamento foi negativa, o paciente tinha 2,175 
mais chance de cicatrização (p=0,0001). Os resultados mostram associação entre a negativação da IFI 
e a cicatrização das lesões quando o primeiro retorno foi até 120 dias e que as chances de cicatrização 
são significativamente maiores nos pacientes que apresentaram IFI negativa no primeiro retorno depois 
do tratamento.
Unitermos: Leishmaniose cutânea/tratamento. Leishmania (Viannia) braziliensis. Lesão cutânea/
cicatrização.
INTRODUCTION
American cutaneous leishmaniasis (ACL) is an ende-
mic disease in Brazil, occurring in every state in the country. 
It affects people of both sexes and all age groups. The main 
species of sand flies that cause ACL in Brazil are Leishmania 
(Viannia) braziliensis (Vianna, 1911), Leishmania (Viannia) 
guyanensis (Floch, 1954) and Leishmania (Leishmania) 
amazonensis (Lainson, Shaw, 1972) (Brasil, 2000).
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ACL has been recorded in the majority of cities 
in the state of Paraná (Roberto et al., 1997; Silveira et 
al., 1999; Lima et al., 2002), which accounts for 98% 
of cases in the southern region of Brazil (Brasil, 2000). 
The success of ACL treatment is limited. The clinical 
control of treatment is imprecise, and relapses, even 
after complete treatment and healing of the initial le-
sions, have been documented (Guevara et al., 1993). The 
first-choice drug in Brazil for treating ACL is N-methyl 
glucamine antimoniate (Glucantime®). According to the 
World Health Organization (WHO, 1995), more than 
90% of relapses occur within one year of treatment. 
Furthermore, the mucosal form may occur among these 
patients, generally appearing months or even years after 
the resolution of the skin lesions. Antibodies detected by 
indirect immunofluorescence assay (IFA) are negative 
after successful treatment of the disease (Furtado, 1980; 
Souza et al., 1982). The presence of anti-Leishmania 
antibodies after treatment may signify the persistence of 
the parasite, and the reduction of antibody titers has been 
suggested as a tool for the control of treatment efficacy 
(Chiari, Mayrink, Magalhães, 1973; Mendonça et al., 
1988). Therefore, the following-up of patients by clini-
cal and serological evaluation is fundamental (Roberto 
et al., 1997).
The objective of this research was to study the possi-
ble association of the variables sex, IFA at initial diagnosis, 
IFA at first return, IFA at different post-treatment periods 
and IFA at last return for clinical evaluation for the healing 
of lesions in ACL patients. To this end, a group of ACL 
patients were followed-up for varying periods after clinical 
and laboratorial diagnosis, after which the contribution of 
each variable was analyzed.
MATERIAL AND METHODS
Patients
One hundred and sixty-three ACL patients, regis-
tered in the 13th Health Region of Cianorte, in northwest 
Paraná from September, 2000 to December, 2003 were 
selected. Treatment was prescribed for all patients after 
positive clinical and/or laboratorial diagnoses. All patients 
were instructed to return for clinical evaluation and collec-
tion of blood samples for the IFA. The follow-up period of 
the patients varied from 22 to 696 days from the start of 
treatment, with all patients being evaluated at least once 
after treatment. The total number of evaluations (including 
initial diagnosis and subsequent returns) varied from two 
to five for each patient.
Laboratorial diagnosis
The laboratorial tests for ACL used in this study 
were Direct Parasite Search (DPS), Montenegro Skin Test 
(MST), and Indirect Immunofluorescence Assay (IFA). 
In the DPS, lesion samples were collected by scraping. 
Smears were made on glass slides, stained by Giemsa, 
and examined by microscope for the presence of amas-
tigote forms. The MST reagent consisted of Leishmania 
(L.) amazonensis promastigotes containing 40 µg/mL of 
protein nitrogen, kindly supplied by the Immunobiological 
Production and Research Center of the Paraná State Health 
Office. The test was considered positive when an indura-
tion diameter greater than or equal to 5mm was observed 
48 hours after inoculation. The IFA for IgG was carried out 
using promastigote forms of Leishmania (V.) braziliensis. 
The serum was diluted, beginning at 1/20. Samples with 
titers equal to or greater than 40 were considered positive 
(Silveira et al., 1999).
Treatment protocol
The patients were intravenously treated with N-me-
thyl glucamine antimoniate at 15 mg Sb5+/kg per day (Bra-
sil, 2000). Five patients did not respond to this treatment 
protocol. Therefore, three of these non-responders were 
also treated with Pentamidine® (pentamidine isothiocya-
nate), one with Pentamidine and intralesional infiltration 
with pentavalent antimonial, and one with intralesional 
infiltration only. The patients were considered clinically 
cured after complete healing of their lesions.
Ethical issues
This study complied with Resolution No. 196/96 of 
the National Health Council of the Brazilian Ministry of 
Health, and was approved by the Permanent Committee 
for Ethics in Research Involving Humans of the State 
University of Maringá (No. 006/2004).
Statistical analysis
An exploratory analysis of the data was carried out 
and Fisher’s exact test was used to verify the associations. 
Logistic regression was used to verify which variables 
contributed significantly to the healing of the lesions, using 
the patients’ first return for clinical and serological evalu-
ation as a parameter. The statistical analyses were carried 
out with the software SAS 8.02 (Statistical Analyses 
System) using the logistic procedure PROC LOGISTIC 
with the “stepwise” selection to determine which variables 
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contributed to healing. Variables were considered signifi-
cant at the 5% significance level.
The following variables were considered in the lo-
gistic regression model: sex, age, IFA at initial diagnosis 
(IFA_ini), IFA at first return (IFA_ret) and the number of 
days until the first return (days). The dependent variable 
was lesion healing by first return (Cret). The following 
categorizations were used: sex: 1 for male and –1 for 
female; IFA_ini: 1 if negative and –1 if positive; IFA_ret: 
1 if negative and –1 if positive; days: 1 if the first return 
occurred within a maximum of 120 days and –1 if the first 
return occurred after 120 days; Cret: 1 if healed and 0 if 
not healed.
The results found through the statistical analysis 
showed that the age variable was not significant for the 
model (p=0.7507). Therefore, the adjusted model was 
given as:
where: b
0
= 1.6002, b
1
= - 0.5272, b
2
= 0.6203, b
3
= 0.7769 
and b
4
= 0.2843.
RESULTS
Of the 163 cases of ACL studied, 127 (77.9%) were 
male and 36 (22.1%) female. Patient age ranged between 
2 and 79 years (median = 33 years), 8.6% were aged up 
to 15 years and 6.8% were over 65. All the patients had 
cutaneous forms of ACL. One hundred and ten patients 
(67.5%) had a single lesion, 31 (19.0%) had two lesions 
and 12 (7.4%) had three or more. It was not possible to 
obtain this information for 10 patients. Two patients had 
negative DPS results, with IFA and MST not being carried 
out, and were included in the sample due to their clinical 
diagnoses.
Table 1 shows that the laboratorial diagnoses of 161 
(98.8%) patients were positive for ACL on at least one of 
the methods used. The DPS was positive in 101 of the 160 
patients submitted to the examination (63.1%), while the 
MST was positive in 134 out of 144 patients (93.1%), and 
the IFA positive in 141 out of 163 patients (86.5%). The 
diagnosis was confirmed by all three laboratorial methods 
in 75 (46.0%) patients. Of the 62 patients with negative 
results on the DPS, or who were not submitted to the DPS, 
40 (64.5%) had positive IFA and MST results, 12 (19.4%) 
had positive MST results only and 8 (12.9%) had positive 
IFA results only.
In the follow-up of the 163 patients, 139 (85.3%) 
showed the healing of lesions by their last return for clini-
cal evaluation (Table II). In 115 (82.7%) of these patients, 
IFA was negative, indicating an association between the 
healing of lesions and the negativity of IFA (p=0.000). Ho-
wever, 24 patients (17.3%) continued to have positive IFA 
results despite having healed lesions. Of the 24 patients 
that did not show healing of lesions, 17 (70.8%) continued 
to have positive IFA results.
Table III shows the results of the clinical and sero-
logic evaluations of the followed-up patients. Of the 81 
evaluations performed within 120 days of treatment, 51 
patients (63.0%) showed healing of lesions, 41 of whom 
(80.2%) had negative IFA results. Thirty patients (37.0%) 
showed no healing of lesions, six of whom (20.0%) had 
negative IFA results. A significant association (p=0.0000) 
was observed between IFA negativity and the healing of 
lesions within this evaluation period. Of the 78 patients 
followed-up from 121 to 210 days, 57 (73.1%) showed 
TABLE I - Results of direct parasite search (DPS), Montenegro 
skin test (MST) and indirect immunofluorescence assay (IFA), 
carried out in the diagnosis of American cutaneous leishmaniasis 
(ACL) in the 163 patients studied from 2000 to 2003
DPS MST
IFA
Total
Positive Negative
Positive
(n=101)
Positive 75 7 82
Negative 8 0 8
NP 10 1 11
Negative
(n=59)
Positive 37 12 49
Negative 2 0 2
NP 6 2 8
NP
(n=3)
Positive 3 0 3
Negative 0 0 0
NP 0 0 0
Total 141 22 163
NP=Not Performed
TABLE II - Results on indirect immunofluorescence assay 
(IFA) and of lesion healing in the 163 patients with American 
cutaneous leishmaniasis (ACL) at last return for clinical 
evaluation during post-treatment follow-up from 2000 to 2003
Healed IFA Total
Negative Positive
Yes 115 24 139
No 7 17 24
Total 122 41 163
Fisher’s exact test, p=0.0000
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healing of lesions while 42 (73.7%) had a negative IFA. 
Twenty-one (26.9%) patients from this group showed no 
healing of lesions, nine of whom (42.9%) had a negative 
IFA (p=0.0552). Of the 51 patients followed-up from 211 
to 365 days, 41 (80.4%) showed healing of lesions, and of 
these 30 (73.2%) had a negative IFA. Ten (19.6%) of these 
patients showed no healing of lesions and four (40.0%) had 
a negative IFA (p=0.0552). Finally, of the twelve patients 
followed-up after 365 days, ten (83.3%) showed healing 
of lesions, five of whom (50.0%) had a negative IFA. Two 
(20.0%) patients from this group presented no healing of 
lesions and showed IFA positivity (p=0.3182).
The results of clinical and serologic evaluations 
performed during other periods (121 to 210 days, 211 
to 365 days, and over 365 days) were also analyzed. 
However, no significant associations between IFA nega-
tivity and the healing of lesions were observed for these 
periods (p>0.05). 
As a significant association (p=0.0000) was obser-
ved between IFA negativity and the healing of lesions in 
the period up to 120 days, logistic regression was perfor-
med on the data from this period to analyze the possible 
factors associated to lesion healing. It was observed that 
patients who had a negative IFA on their first return after 
treatment had a 2.175 greater likelihood of their lesions 
healing than when IFA was positive (p=0.0001; CI=1.490-
3.174) (Table IV). Analysis of other factors such as gender, 
IFA result at initial diagnosis, and time of first return after 
treatment (up to 120 days or after 120 days) found no 
associations with lesion healing (p>0.05).
DISCUSSION
The majority of the patients studied were from the 
male working-class population, suggesting an extra-domi-
TABLE III - Results on indirect immunofluorescence assay 
(IFA) and for lesion healing in the 163 patients with American 
cutaneous leishmaniasis (ACL) during different post-treatment 
periods from 2000 to 2003
Time (days) Healed IFA Total p
Negative Positive
≤ 120 Yes 41 10 51 0.0000
No 6 24 30
Sub Total 47 34 81
121 to 210 Yes 42 15 57 0.0552
No 9 12 21
Sub Total 51 27 78
211 to 365 Yes 30 11 41 0.0552
No 4 6 10
Sub Total 34 17 51
> 365 Yes 5 5 10 0.3182
No 0 2 2
Sub Total  5 7 12
Total  137 85 222*
*After initial diagnosis, 114 patients returned once, 42 twice, 5 
three times, 1 four times and 1 five times, amounting to a total of 
222 blood samples subjected to IFA; p: value of Fisher’s exact 
test: IFA versus healing.
TABLE IV - Logistic regression analysis of factors associated with healing of lesions in 163 patients with American cutaneous 
leishmaniasis (ACL), followed-up from 2000 to 2003
Variables
Healed Odds Ratio 
(95% confidence interval)
Chi-squared p
Yes No
Gender
Male 81 46 0.590
(0.344 – 1.013)
3.6662 0.0555
Female 31 5
IFA on initial diagnosis 
Positive 92 49 1.859
(0.848 – 4.076)
2.3993 0.1214
Negative 20 2
IFA on First Return$(within 120 days)
Positive 30 35 2.175
(1.490 – 3.174)
16.2201 0.0001
Negative 82 16
Time of First Return
Within 120 days 49 30 1.329
(0.915 – 1.930)
2.2320 0.1352
>120 days 63 21
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ciliary transmission of ACL, as was previously observed in 
the north of the state of Paraná (Silveira et al., 1999; Castro 
et al., 2002). However, the occurrence of cases in the age 
ranges of up to 15 and over 65 years, for both sexes, also 
suggests intra- or peri-domiciliary transmission occurred, 
corroborating data from the north of Paraná State (Roberto 
et al., 1997; Lima et al., 2002) and on an endemic area 
of the State of Minas Gerais, Brazil (Passos et al., 2001).
In the present study, IFA showed a higher rate of 
positivity than the MST or DPS in the diagnosis of ACL, 
contrasting with results obtained by Silveira et al. (1999), 
who found higher positivity for the MST in patients from 
the same geographical area. The sensitivity of IFA in the 
present study was similar to that found in studies on other 
endemic areas (Marzochi et al., 1980; Lugo de Yarbuh 
et al., 1996). Together, the three methods used for ACL 
diagnosis were able to detect 98.8% of the ACL cases, 
showing it to be a useful combination for diagnosing the 
disease (Gontijo, Carvalho, 2003).
A highly significant association between the hea-
ling of lesions and negative IFA results was observed in 
this study, confirming that successful treatment reduces 
levels of anti-Leishmania antibodies (Amato et al., 
1998). Romero et al. (2005) also observed a reduction 
in antibody levels on enzyme-linked immunosorbent 
assay (ELISA) post treatment. Therefore, the reduction 
of anti-Leishmania antibody levels after treatment could 
be an important tool in the control of ACL treatment 
(Mendonça et al., 1988). 
The data for different post-treatment periods was 
analyzed in order to identify the optimal time after treat-
ment to evaluate the association between the healing of 
lesions and IFA seroconversion. The analysis showed that 
lesion healing was associated to negative IFA results when 
the evaluation was carried out in the period of up to 120 
days after treatment. According to Passos et al. (2001), the 
treatment and elimination of the parasites induces lower 
antigenic stimulation, which contributes to IFA negativity, 
and Saravia et al. (1989) showed that there was an associa-
tion between longer lesion evolution time and higher IFA 
titers in patients infected with L. braziliensis. 
In the present study, a tendency of IFA negativity 
seen among those patients whose lesions had healed and 
who were analyzed during the periods of 121 to 210 and 
211 to 365 days after treatment (p=0.0552). However, no 
association was observed between IFA negativity and the 
healing of lesions in those patients evaluated 365 days 
or more after treatment. This suggests that patients who 
continue to have antibody titers show a tendency to evolve 
to the chronic disease, or the reappearance of cutaneous 
and/or mucosal lesions. 
Attention is drawn to the group of patients (17.3%) 
whose lesions healed but for whom IFA results remained 
positive. The persistence of antibodies may be an impor-
tant indicator of the persistence of the parasite, despite 
the healing of their lesions. Indeed the persistence of the 
parasite in healed lesions was demonstrated by Mendonça 
et al. (2004). These authors obtained 30 positive PCR and 
7 positive IFA results from 32 clinically cured patients, 
indicating the tendency of Leishmania to establish non-
apparent infections (Ramirez, Guevara, 1997). Chiari et 
al. (1973) found that 38% of patients submitted to treat-
ment, and considered clinically cured, continued to have 
positive IFA results. Passos et al. (2001) did not associate 
the risk of recurrence to antibody levels measured by IFA; 
however, Amato et al. (1998) argued that the negativity 
of IFA antibody titers indicates a lower possibility of re-
currence. These observations suggest that a more rigorous 
following-up of ACL patients, as well as their medicinal 
dosage and treatment protocol, through clinical and labo-
ratory evaluations, is necessary.
Of the patients whose lesions did not heal, IFA re-
sults remained positive for 80.0% and 57.1% during the 
periods of up to 120 days and from 121 to 210 days, res-
pectively, showing the failure of the treatment. Different 
degrees of susceptibility to treatment, as well as different 
levels of immunological response, have been related to 
the various serodemes (Shaw et al., 1986) of Leishma-
nia (Viannia) braziliensis that circulate in the northwest 
region of Paraná State (Silveira et al., 1999). While some 
infections by Leishmania present complications during 
treatment, sometimes producing metastasis and recurren-
ce, others evolve to a spontaneous cure, suggesting that 
the immunological response is capable of controlling the 
infection (Brito et al., 2001). 
In the present study, it was shown that the chances 
of lesions healing are greater if the IFA performed is ne-
gative when the patient first return after treatment. This 
indicates that both the initial diagnosis and the start of 
treatment were probably early. Neither IFA positivity at 
initial diagnosis, nor the time of the first return for evalua-
tion of treatment, were found to be factors associated with 
the healing of lesions. No differences in lesion healing 
between men and women were found, despite the findin-
gs of Travi et al. (2002), who studied hamsters infected 
with Leishmania (Viannia) and observed that the immune 
response was more permissive to infection among males 
than females. The factors that contribute to the cutaneous 
disease evolving into one of the later forms are not fully 
understood, but delay in healing the first lesion and ina-
dequate treatment are both known predictors (Carvalho 
et al., 1995).
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CONCLUSIONS
The findings of this study confirm that: a) there is 
an association between IFA negativity at the first return of 
the patient within 120 days of treatment and the healing 
of lesions, and b) the chances of healing are significantly 
higher in patients that showed negative IFA results on their 
first return for clinical evaluation after treatment.
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